Halozyme Therapeutics, Inc. (HALO) Earnings Per Share (EPS)
Halozyme Therapeutics, Inc. (HALO) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | $0.03 |
| 2017-12-31 | $0.46 |
| 2018-12-31 | -$0.56 |
| 2019-12-31 | -$0.50 |
| 2020-12-31 | $0.95 |
| 2021-12-31 | $2.86 |
| 2022-12-31 | $1.48 |
| 2023-12-31 | $2.13 |
| 2024-12-31 | $3.50 |
| 2025-12-31 | $2.64 |
How HALO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| PODD | Insulet Corporation | $3.48 |
| BMY | Bristol-Myers Squibb Company | $3.46 |
| HSIC | Henry Schein Inc. | $3.27 |
| ALNY | Alnylam Pharmaceuticals Inc. | $2.33 |
| BSX | Boston Scientific Corporation | $1.94 |
These are five companies in the same sector as HALO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("HALO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HALO | $98.66 | +0.00% | 1.98M |
| 3 | ||||
| 4 | ||||
| 5 |